News, Analysis & Insights on Nutrition, Supplements, and Health
Initial results from a new study investigating the effects of lutein and zeaxanthin on skin health presented yesterday is expected to open up a whole new market for suppliers of these antioxidants in oral and topical beauty products.
Geni Herbs has announced it is signing over its marketing and distribution of ayurvedic botanicals to Stauber Performance Ingredients in an exclusive partnership, which will allow it to focus on research.
Supplements of the sunshine vitamin could cut the risk of pancreatic cancer in half, says a study led by researchers at Northwestern and Harvard universities.
Soy-powder maker SoyLink has a new US patent for its proprietary technology - a manufacturing process the Iowa-based company says will expand current uses for soy in functional foods and beverages.
Vitatene has received an award from Frost & Sullivan for its proprietary beta-carotene Betanat - signifying a pat on the back for breaking industry ground and bringing prices for the natural ingredient in line with synthetic versions.
Demand and prices for glucosamine have stabilised after a tumultuous couple of years, as the sheen of newness rubs off the joint health ingredient and much-anticipated GAIT trial, though positive, proves disappointing in design.
Drinking several cups of green tea every day could cut peoples' risk of death from a range of diseases, but does not appear to lower the chances of getting cancer, says a Japanese study.
Martek Biosciences is pressing ahead with its plan to grow sales of its microalgae-derived DHA in European infant formula and mainstream foods now that supply issues have been resolved, despite pending patent litigation with competitors.
Nutrition 21 has reported sales on a par with last year in full year 2006 and increased losses, but believes it is on the cusp of great things for the coming year as it fully implements its shift from ingredients to finished products and chases new...
Europharma has signed a deal with New Chapter to take Vectomega into theretail sector, a move it expects will up the stakes in bioavailability ofsupplement products available on the US market.
New manufacturer and marketer Calgenex Corporation is taking the condition-specific approach to supplementation to a very specific level - tackling soft tissue calcification with a range of products.